- Home
- BPMC vs HOMB Comparison
BPMC vs HOMB Comparison
Compare BPMC & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- HOMB
- Stock Information
- Founded
- BPMC 2008
- HOMB 1998
- Country
- BPMC United States
- HOMB United States
- Employees
- BPMC N/A
- HOMB N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- HOMB Major Banks
- Sector
- BPMC Health Care
- HOMB Finance
- Exchange
- BPMC Nasdaq
- HOMB Nasdaq
- Market Cap
- BPMC 5.8B
- HOMB 5.0B
- IPO Year
- BPMC 2015
- HOMB 2006
- Fundamental
- Price
- BPMC $128.35
- HOMB $29.81
- Analyst Decision
- BPMC Buy
- HOMB Hold
- Analyst Count
- BPMC 20
- HOMB 5
- Target Price
- BPMC $127.82
- HOMB $31.00
- AVG Volume (30 Days)
- BPMC 3.6M
- HOMB 951.4K
- Earning Date
- BPMC 07-31-2025
- HOMB 07-16-2025
- Dividend Yield
- BPMC N/A
- HOMB 2.62%
- EPS Growth
- BPMC N/A
- HOMB 8.29
- EPS
- BPMC N/A
- HOMB 2.09
- Revenue
- BPMC $562,121,000.00
- HOMB $987,214,000.00
- Revenue This Year
- BPMC $44.46
- HOMB $11.25
- Revenue Next Year
- BPMC $32.78
- HOMB $2.78
- P/E Ratio
- BPMC N/A
- HOMB $14.26
- Revenue Growth
- BPMC 99.19
- HOMB 1.15
- 52 Week Low
- BPMC $73.04
- HOMB $23.23
- 52 Week High
- BPMC $128.52
- HOMB $32.91
- Technical
- Relative Strength Index (RSI)
- BPMC 74.59
- HOMB 67.22
- Support Level
- BPMC $128.06
- HOMB $28.28
- Resistance Level
- BPMC $128.52
- HOMB $28.83
- Average True Range (ATR)
- BPMC 0.28
- HOMB 0.53
- MACD
- BPMC -1.18
- HOMB 0.20
- Stochastic Oscillator
- BPMC 74.44
- HOMB 90.97
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About HOMB Home BancShares Inc.
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.